Cozaar/Hyzaar News
Most Popular Cozaar/Hyzaar Story
Cozaar/Hyzaar - Big Patent Expirations of 2010
Drug: Cozaar (losartan potassium)/Hyzaar (hydrochlorothiazide; losartan potassium)Company: MerckIndication: HypertensionPatent Expiration: Aug. 11, 2009/Pediatric Exclusivity through Feb. 11 Scoop: Read more...
Latest Headlines
- July 16, 2010
- March 3, 2010
- February 10, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
